Alimera Sciences Inc. (ALIM)
NASDAQ: ALIM
· Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 8:00 PM
-0.18% (1D)
| Bid | n/a |
| Market Cap | 301.29M |
| Revenue (ttm) | 99.68M |
| Net Income (ttm) | -14.7M |
| EPS (ttm) | 1.05 |
| PE Ratio (ttm) | 5.276190476190476 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 2,677,974 |
| Avg. Volume (20D) | 866,825 |
| Open | 5.55 |
| Previous Close | 5.55 |
| Day's Range | 5.53 - 5.56 |
| 52-Week Range | 2.61 - 5.65 |
| Beta | 1.25 |
About ALIM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALIM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALIM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
-6.49%
Alimera Sciences shares are trading lower after th...
Unlock content with
Pro Subscription
10 months ago
+75.87%
Alimera Sciences shares are trading higher after the company announced that signed a definitive agreement to be acquired by ANI Pharmaceuticals.